ABBV:NYE-AbbVie Inc (USD)

COMMON STOCK | Drug Manufacturers—General | NYE

Last Closing Price

USD 96.83

Change

0.00 (0.00)%

Market Cap

USD 170.65B

Volume

6.20M

Average Target Price

USD 102.29 (+5.63%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-07-11 )

Largest Industry Peers for Drug Manufacturers—General

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
JNJ Johnson & Johnson

N/A

USD375.34B 22.23 14.45
NVS Novartis AG

N/A

USD198.97B 27.28 14.44
MRK Merck & Co., Inc

N/A

USD193.67B 19.73 13.00
PFE Pfizer Inc

N/A

USD187.92B 12.05 9.35
LLY Eli Lilly and Company

N/A

USD156.25B 28.24 22.81
AZN AstraZeneca PLC

N/A

USD139.80B 94.24 23.94
BMY Bristol-Myers Squibb Company

N/A

USD129.95B 94.54 21.25
GSK GlaxoSmithKline plc

N/A

USD99.64B 15.03 15.03
AGN Allergan plc

N/A

USD63.66B 22.00 28.44

ETFs Containing ABBV

Symbol Name Weight Mer Price(Change) Market Cap
BOUT Innovator IBD Breakout Op.. 6.87 % 0.84 %

N/A

USD5.49M
ACT AdvisorShares Vice ETF 6.00 % 0.99 %

N/A

USD9.13M
DHS WisdomTree U.S. High Divi.. 5.90 % 0.38 %

N/A

USD0.71B
PPH VanEck Vectors Pharmaceut.. 5.78 % 0.36 %

N/A

USD0.23B
WTD9:F WisdomTree Issuer ICAV - .. 5.63 % 0.29 %

N/A

N/A
WTDY:F WisdomTree Issuer ICAV - .. 5.63 % 0.35 %

N/A

N/A
DHS:LSE WisdomTree Issuer ICAV - .. 5.63 % 0.29 %

N/A

N/A
WTEU:F WisdomTree Issuer ICAV - .. 5.63 % 0.29 %

N/A

N/A
DHSP:LSE WisdomTree Issuer ICAV - .. 5.63 % 0.29 %

N/A

N/A
DHSG:LSE WisdomTree Issuer ICAV - .. 5.63 % 0.35 %

N/A

N/A
WTDY:XETRA WisdomTree Issuer ICAV - .. 5.63 % 0.35 %

N/A

N/A
WTEU:XETRA WisdomTree US Equity Inco.. 5.63 % 0.29 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 5.63 % 0.29 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 5.39 % 0.56 %

N/A

USD0.36B
LIFE:CA Evolve Global Healthcare .. 5.38 % 0.45 %

N/A

USD0.01B
FDL First Trust Morningstar D.. 5.29 % 0.45 %

N/A

USD1.27B
HHL-U:CA Harvest Healthcare Leader.. 5.21 % 0.85 %

N/A

N/A
HHL:CA Harvest Healthcare Leader.. 5.21 % 0.85 %

N/A

USD0.33B
ZWH:CA BMO US High Dividend Cove.. 5.05 % 0.65 %

N/A

USD0.75B
ZWH-U:CA BMO US High Dividend Cove.. 5.05 % 0.65 %

N/A

N/A
FHI-B:CA CI First Asset Health Car.. 5.00 % 0.65 %

N/A

N/A
FHI:CA CI First Asset Health Car.. 5.00 % 0.65 %

N/A

USD0.20B
DHSA:LSE WisdomTree Issuer ICAV - .. 4.72 % 0.29 %

N/A

N/A
DHSD:LSE WisdomTree Issuer ICAV - .. 4.72 % 0.29 %

N/A

N/A
WBIG WBI BullBear Yield 3000 E.. 4.59 % 1.04 %

N/A

USD0.06B
WBIF WBI BullBear Value 3000 E.. 4.58 % 1.18 %

N/A

USD0.04B
RDIV Invesco S&P Ultra Dividen.. 4.53 % 0.39 %

N/A

USD0.65B
ZPDH:XETRA SPDR S&P U.S. Health .. 4.23 % 0.15 %

N/A

USD0.26B
IHCU:LSE iShares S&P 500 Health Ca.. 4.23 % 0.15 %

N/A

USD1.69B
QDVG:XETRA iShares S&P 500 Healt.. 4.23 % 0.15 %

N/A

USD1.69B
ZPDH:F SPDR S&P U.S. Health .. 4.23 % 0.15 %

N/A

USD0.26B
SXLV:LSE SPDR S&P U.S. Health .. 4.23 % 0.15 %

N/A

USD0.26B
QDVG:F iShares V Public Limited .. 4.23 % 0.15 %

N/A

USD1.69B
IYH iShares U.S. Healthcare E.. 4.18 % 0.43 %

N/A

USD2.33B
XLV Health Care Select Sector.. 4.18 % 0.13 %

N/A

USD23.23B
WBIY WBI Power Factor High Div.. 4.07 % 0.70 %

N/A

USD0.04B
HID:CA WisdomTree U.S. High Divi.. 4.06 % 0.40 %

N/A

USD4.31M
XUHC:XETRA Xtrackers (IE) Public Lim.. 4.01 % 0.12 %

N/A

USD0.69B
XSHC:LSE Xtrackers (IE) Public Lim.. 4.01 % 0.12 %

N/A

USD0.69B
SDG iShares Trust - iShares M.. 3.81 % 0.49 %

N/A

USD0.10B
MJMT:F Amundi Index Solutions - .. 3.68 % 0.00 %

N/A

USD0.35B
MJMT:XETRA Amundi Index Solutions - .. 3.68 % 0.00 %

N/A

USD0.35B
IUHC:LSE iShares S&P 500 Healt.. 3.67 % 0.15 %

N/A

USD1.17B
FHLC Fidelity MSCI Health Care.. 3.63 % 0.08 %

N/A

USD1.91B
XUHC:LSE Xtrackers (IE) Public Lim.. 3.45 % 0.12 %

N/A

USD0.40B
LNGR Global X Longevity Themat.. 3.10 % 0.50 %

N/A

USD0.03B
IXJ iShares Global Healthcare.. 3.01 % 0.46 %

N/A

USD2.17B
XHC:CA iShares Global Healthcare.. 2.89 % 0.63 %

N/A

USD0.36B
WHEA:LSE SPDR MSCI World Health Ca.. 2.76 % 0.30 %

N/A

USD0.30B
XDWH:LSE Xtrackers MSCI World Heal.. 2.73 % 0.30 %

N/A

USD0.93B
XDWH:F Xtrackers MSCI World Heal.. 2.73 % 0.30 %

N/A

USD0.93B
XDWH:XETRA Xtrackers MSCI World Heal.. 2.73 % 0.30 %

N/A

USD0.93B
ZDY-U:CA BMO US Dividend ETF (USD) 2.62 % 0.30 %

N/A

N/A
ZDY:CA BMO US Dividend ETF (CAD) 2.62 % 0.30 %

N/A

USD1.33B
DEW WisdomTree Global High Di.. 2.55 % 0.58 %

N/A

USD0.08B
LVHD Legg Mason Low Volatility.. 2.54 % 0.27 %

N/A

USD0.66B
SPDV AAM S&P 500 High Dividend.. 2.46 % 0.29 %

N/A

USD0.02B
UDVD:LSE SPDR® S&P US Dividend Ar.. 2.26 % 0.35 %

N/A

USD2.77B
DTN WisdomTree U.S. Dividend .. 2.18 % 0.38 %

N/A

USD0.53B
ZHU:CA BMO Equal Weight US Healt.. 2.13 % 0.35 %

N/A

USD0.03B
DSTL Distillate U.S. Fundament.. 2.12 % 0.39 %

N/A

USD0.12B
JHMH John Hancock Multifactor .. 2.12 % 0.40 %

N/A

USD0.04B
RNDV First Trust US Equity Div.. 2.12 % 0.50 %

N/A

USD4.11M
VALQ American Century STOXX U... 2.12 % 0.29 %

N/A

USD0.13B
SPYD SPDR Series Trust - SPDR .. 2.11 % 0.07 %

N/A

USD1.80B
ZUH:CA BMO Equal Weight US Healt.. 2.11 % 0.35 %

N/A

USD0.39B
JKD iShares Morningstar Large.. 2.04 % 0.20 %

N/A

USD0.75B
FDRR Fidelity Dividend ETF for.. 2.01 % 0.29 %

N/A

USD0.28B
DLN WisdomTree U.S. LargeCap .. 1.90 % 0.28 %

N/A

USD2.19B
GENE:LSE UBS (Irl) ETF plc - Globa.. 1.87 % 0.00 %

N/A

N/A
RYH Invesco S&P 500 Equal Wei.. 1.81 % 0.40 %

N/A

USD0.69B
CUD:CA iShares US Dividend Growe.. 1.76 % 0.60 %

N/A

USD0.35B
SPYD:XETRA SSgA SPDR ETFs Europe I P.. 1.73 % 0.35 %

N/A

USD2.77B
USDV:LSE SSgA SPDR ETFs Europe I P.. 1.73 % 0.35 %

N/A

N/A
SPYD:F SSgA SPDR ETFs Europe I P.. 1.73 % 0.35 %

N/A

USD2.77B
DTD WisdomTree U.S. Total Div.. 1.72 % 0.28 %

N/A

USD0.70B
UC86:LSE UBS ETF - Bloomberg Barcl.. 1.68 % 0.18 %

N/A

N/A
UEF8:XETRA UBS ETF - Bloomberg Barcl.. 1.58 % 0.23 %

N/A

N/A
UEF7:F UBS ETF - Bloomberg Barcl.. 1.58 % 0.18 %

N/A

N/A
UC81:LSE UBS ETF - Bloomberg Barcl.. 1.58 % 0.18 %

N/A

N/A
UC82:LSE UBS ETF - Bloomberg Barcl.. 1.58 % 0.23 %

N/A

N/A
PY Principal Exchange-Traded.. 1.56 % 0.29 %

N/A

USD0.03B
CATH Global X S&P 500 Catholic.. 1.42 % 0.29 %

N/A

USD0.35B
CAPS:CA Evolve Active US Core Equ.. 1.38 % 0.70 %

N/A

USD3.62M
GEND:LSE Lyxor International Asset.. 1.26 % 0.35 %

N/A

USD0.02B
ESGW Columbia Sustainable Glob.. 0.93 % 0.40 %

N/A

USD0.01B
UC98:LSE UBS ETF - Bloomberg Barcl.. 0.76 % 0.20 %

N/A

N/A
BSUS:LSE UBS ETF - Bloomberg Barcl.. 0.76 % 0.25 %

N/A

N/A
UEF0:F UBS ETF - Bloomberg Barcl.. 0.75 % 0.23 %

N/A

N/A
UEF0:XETRA UBS ETF - Bloomberg Barcl.. 0.75 % 0.23 %

N/A

N/A
UEF9:XETRA UBS ETF - Bloomberg Barcl.. 0.75 % 0.18 %

N/A

N/A
UC76:LSE UBS ETF - Bloomberg Barcl.. 0.75 % 0.18 %

N/A

N/A
UC85:LSE UBS ETF - Bloomberg Barcl.. 0.75 % 0.23 %

N/A

N/A
UEF9:F UBS ETF - Bloomberg Barcl.. 0.75 % 0.18 %

N/A

N/A
TSWE:XETRA VanEck Vectors ETFs N.V. .. 0.55 % 0.30 %

N/A

USD0.12B
ERM EquityCompass Risk Manage.. 0.49 % 0.65 %

N/A

USD0.01B
TERM EquityCompass Tactical Ri.. 0.49 % 0.73 %

N/A

USD0.01B
LUSC:LSE SPDR Bloomberg Barclays 1.. 0.49 % 0.20 %

N/A

USD0.15B
SUSC:LSE SPDR Bloomberg Barclays 0.. 0.42 % 0.20 %

N/A

USD0.10B
SYBR:XETRA SPDR Bloomberg Barclays 1.. 0.38 % 0.20 %

N/A

USD0.07B
SYBR:F SPDR Bloomberg Barclays 1.. 0.38 % 0.20 %

N/A

USD0.07B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

N/A

USD0.13B
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

N/A

USD0.10B
IGIB iShares Intermediate-Term.. 0.00 % 0.06 %

N/A

USD10.71B
VDIV:XETRA Think Morningstar® High .. 0.00 % 0.00 %

N/A

N/A
DIVA AGFiQ Hedged Dividend Inc.. 0.00 % 1.10 %

N/A

USD3.08M
SSO ProShares Ultra S&P500 0.00 % 0.90 %

N/A

USD2.29B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

N/A

USD0.57B
SPXT ProShares S&P 500 ex-Tech.. 0.00 % 0.27 %

N/A

USD2.69M
SPXN ProShares S&P 500 ex-Fina.. 0.00 % 0.27 %

N/A

USD4.31M
SDYL UBS ETRACS Monthly Pay 2x.. 0.00 % 0.30 %

N/A

USD0.01B
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

USD2.46M
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

N/A

USD1.23B
IBDQ iShares iBonds Dec 2025 T.. 0.00 % 0.10 %

N/A

USD0.68B
IBDN iShares iBonds Dec 2022 T.. 0.00 % 0.10 %

N/A

USD1.30B
UC84:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.00 %

N/A

N/A
IBDL iShares iBonds Dec 2020 T.. 0.00 % 0.10 %

N/A

USD1.11B
LABU Direxion Daily S&P Biotec.. 0.00 % 1.04 %

N/A

USD0.39B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

N/A

USD54.02B
AWTM Aware Ultra-Short Duratio.. 0.00 % 0.23 %

N/A

USD0.33B
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

USD2.46M
RALS ProShares RAFI Long/Short 0.00 % 0.95 %

N/A

USD5.27M
RWDC Direxion MSCI Defensives .. 0.00 % 0.46 %

N/A

USD7.11M

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers—General)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.36% 89% B+ 88% B+
Dividend Return 1.33% 22% F 57% F
Total Return 10.70% 89% B+ 88% B+
Trailing 12 Months  
Capital Gain 37.78% 89% B+ 93% A
Dividend Return 3.20% 44% F 66% D
Total Return 40.98% 89% B+ 93% A
Trailing 5 Years  
Capital Gain 39.87% 67% D+ 81% B-
Dividend Return 21.54% 89% B+ 73% C
Total Return 61.40% 78% C+ 83% B
Average Annual (5 Year Horizon)  
Capital Gain 11.60% 82% B- 76% C
Dividend Return 4.10% 82% B- 73% C
Total Return 15.70% 82% B- 80% B-
Risk Return Profile  
Volatility (Standard Deviation) 28.81% 9% F 21% F
Risk Adjusted Return 54.50% 45% F 53% F
Market Capitalization 170.65B 56% F 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers—General)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.33 78% C+ 44% F
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 12.81 89% B+ 25% F
EV/EBITDA 15.25 44% F 29% F
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 28.37% 100% A+ 96% A
Return on Assets 11.80% 100% A+ 96% A
Debt to Equity Ratio -770.62% 100% A+ 98% A+
Technical Ratios  
Short Ratio 1.94 22% F 45% F
Short Percent 1.12% 33% F 83% B
Beta 0.82 11% F 67% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.